Citation

Rosenquist Å, Samuelsson B, Johansson PO, Cummings MD, Lenz O, Raboisson P, Simmen K, Vendeville S, de Kock H, Nilsson M, Horvath A, Kalmeijer R, de la Rosa G, Beumont-Mauviel M.: Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. J Med Chem, Volume 57 (5), 2014

Authors

Beumont-Mauviel M., Cummings MD, de Kock H, de la Rosa G, Horváth A, Johansson PO, Kalmeijer R, Lenz O, Nilsson M, Raboisson P, Rosenquist A, Samuelsson B, Simmen K, Vendeville S

Journal

J Med Chem

Year

2014

DOI

10.1021/jm401507s

PubMed

24446688

Machine-readable

REST APIRDF